Cargando…
The importance of the Peritoneal Cancer Index (PCI) to predict surgical outcome after neoadjuvant chemotherapy in advanced ovarian cancer
PURPOSE: Achieving complete cytoreduction (CCR) is crucial for a patient’s prognosis with advanced epithelial ovarian cancer (EOC). So far, prognostic predictors have failed to predict surgical outcome after neoadjuvant chemotherapy (NACT). In clinical trials, scores were used to predict operability...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519707/ https://www.ncbi.nlm.nih.gov/pubmed/35357582 http://dx.doi.org/10.1007/s00404-022-06527-y |
_version_ | 1784799460125048832 |
---|---|
author | Rawert, Friederike Luise Luengas-Würzinger, Veronica Claßen-Gräfin von Spee, Sabrina Baransi, Saher Schuler, Esther Carrizo, Katharina Dizdar, Anca Mallmann, Peter Lampe, Björn |
author_facet | Rawert, Friederike Luise Luengas-Würzinger, Veronica Claßen-Gräfin von Spee, Sabrina Baransi, Saher Schuler, Esther Carrizo, Katharina Dizdar, Anca Mallmann, Peter Lampe, Björn |
author_sort | Rawert, Friederike Luise |
collection | PubMed |
description | PURPOSE: Achieving complete cytoreduction (CCR) is crucial for a patient’s prognosis with advanced epithelial ovarian cancer (EOC). So far, prognostic predictors have failed to predict surgical outcome after neoadjuvant chemotherapy (NACT). In clinical trials, scores were used to predict operability in recurrent ovarian cancer (Harter et al. in N Engl J Med 385(23):2123–2131, 2021) but there is no known prediction score for CCR after NACT. The Peritoneal Cancer Index (PCI) is an established tool to predict surgical outcome in primary setting (Lampe et al. in 25:135–144, 2015). We now examined the predictive power of the PCI to achieve CCR after NACT. METHODS: In this single-center study, the data of patients with advanced stage EOC (FIGO > IIIb) treated between 01/2015 and 12/2020 were analyzed retrospectively. Inclusion criteria were a mandatory staging laparoscopy, a PCI score > 25, and NACT. CT scans were analyzed in blinded fashion according to RECIST criteria (Borgani et al. in 237; 93–99, 2019) Reaction of PCI after NACT was compared with the analysis of radiologic imaging and CA-125 levels. RESULTS: Three hundred and sixteen patients were screened, 62 were treated with NACT, and 23 were included in our analysis. 87% of cases presented with an FIGO IIIc stadium. The reduction of PCI itself after NACT showed to be the most powerful predictor for achieving CCR. The reduction of the initial PCI score by minimum of 8.5 points was a better predictor for CCR than reaching a PCI < 25. In contrast to data deriving from patients undergoing primary debulking surgery (PDS), we found a PCI of 17, rather than 25, to be a more valuable cut-off for CCR in neoadjuvant-treated patients. CONCLUSION: The extend of PCI reduction after NACT is a better predictor for achieving CCR compared with CA125 levels and radiologic imaging. The PCI must be assessed differently in neoadjuvant setting than in a primary situation. CCR was most likely for a post-NACT PCI < 17. |
format | Online Article Text |
id | pubmed-9519707 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-95197072022-09-30 The importance of the Peritoneal Cancer Index (PCI) to predict surgical outcome after neoadjuvant chemotherapy in advanced ovarian cancer Rawert, Friederike Luise Luengas-Würzinger, Veronica Claßen-Gräfin von Spee, Sabrina Baransi, Saher Schuler, Esther Carrizo, Katharina Dizdar, Anca Mallmann, Peter Lampe, Björn Arch Gynecol Obstet Gynecologic Oncology PURPOSE: Achieving complete cytoreduction (CCR) is crucial for a patient’s prognosis with advanced epithelial ovarian cancer (EOC). So far, prognostic predictors have failed to predict surgical outcome after neoadjuvant chemotherapy (NACT). In clinical trials, scores were used to predict operability in recurrent ovarian cancer (Harter et al. in N Engl J Med 385(23):2123–2131, 2021) but there is no known prediction score for CCR after NACT. The Peritoneal Cancer Index (PCI) is an established tool to predict surgical outcome in primary setting (Lampe et al. in 25:135–144, 2015). We now examined the predictive power of the PCI to achieve CCR after NACT. METHODS: In this single-center study, the data of patients with advanced stage EOC (FIGO > IIIb) treated between 01/2015 and 12/2020 were analyzed retrospectively. Inclusion criteria were a mandatory staging laparoscopy, a PCI score > 25, and NACT. CT scans were analyzed in blinded fashion according to RECIST criteria (Borgani et al. in 237; 93–99, 2019) Reaction of PCI after NACT was compared with the analysis of radiologic imaging and CA-125 levels. RESULTS: Three hundred and sixteen patients were screened, 62 were treated with NACT, and 23 were included in our analysis. 87% of cases presented with an FIGO IIIc stadium. The reduction of PCI itself after NACT showed to be the most powerful predictor for achieving CCR. The reduction of the initial PCI score by minimum of 8.5 points was a better predictor for CCR than reaching a PCI < 25. In contrast to data deriving from patients undergoing primary debulking surgery (PDS), we found a PCI of 17, rather than 25, to be a more valuable cut-off for CCR in neoadjuvant-treated patients. CONCLUSION: The extend of PCI reduction after NACT is a better predictor for achieving CCR compared with CA125 levels and radiologic imaging. The PCI must be assessed differently in neoadjuvant setting than in a primary situation. CCR was most likely for a post-NACT PCI < 17. Springer Berlin Heidelberg 2022-03-31 2022 /pmc/articles/PMC9519707/ /pubmed/35357582 http://dx.doi.org/10.1007/s00404-022-06527-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Gynecologic Oncology Rawert, Friederike Luise Luengas-Würzinger, Veronica Claßen-Gräfin von Spee, Sabrina Baransi, Saher Schuler, Esther Carrizo, Katharina Dizdar, Anca Mallmann, Peter Lampe, Björn The importance of the Peritoneal Cancer Index (PCI) to predict surgical outcome after neoadjuvant chemotherapy in advanced ovarian cancer |
title | The importance of the Peritoneal Cancer Index (PCI) to predict surgical outcome after neoadjuvant chemotherapy in advanced ovarian cancer |
title_full | The importance of the Peritoneal Cancer Index (PCI) to predict surgical outcome after neoadjuvant chemotherapy in advanced ovarian cancer |
title_fullStr | The importance of the Peritoneal Cancer Index (PCI) to predict surgical outcome after neoadjuvant chemotherapy in advanced ovarian cancer |
title_full_unstemmed | The importance of the Peritoneal Cancer Index (PCI) to predict surgical outcome after neoadjuvant chemotherapy in advanced ovarian cancer |
title_short | The importance of the Peritoneal Cancer Index (PCI) to predict surgical outcome after neoadjuvant chemotherapy in advanced ovarian cancer |
title_sort | importance of the peritoneal cancer index (pci) to predict surgical outcome after neoadjuvant chemotherapy in advanced ovarian cancer |
topic | Gynecologic Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519707/ https://www.ncbi.nlm.nih.gov/pubmed/35357582 http://dx.doi.org/10.1007/s00404-022-06527-y |
work_keys_str_mv | AT rawertfriederikeluise theimportanceoftheperitonealcancerindexpcitopredictsurgicaloutcomeafterneoadjuvantchemotherapyinadvancedovariancancer AT luengaswurzingerveronica theimportanceoftheperitonealcancerindexpcitopredictsurgicaloutcomeafterneoadjuvantchemotherapyinadvancedovariancancer AT claßengrafinvonspeesabrina theimportanceoftheperitonealcancerindexpcitopredictsurgicaloutcomeafterneoadjuvantchemotherapyinadvancedovariancancer AT baransisaher theimportanceoftheperitonealcancerindexpcitopredictsurgicaloutcomeafterneoadjuvantchemotherapyinadvancedovariancancer AT schuleresther theimportanceoftheperitonealcancerindexpcitopredictsurgicaloutcomeafterneoadjuvantchemotherapyinadvancedovariancancer AT carrizokatharina theimportanceoftheperitonealcancerindexpcitopredictsurgicaloutcomeafterneoadjuvantchemotherapyinadvancedovariancancer AT dizdaranca theimportanceoftheperitonealcancerindexpcitopredictsurgicaloutcomeafterneoadjuvantchemotherapyinadvancedovariancancer AT mallmannpeter theimportanceoftheperitonealcancerindexpcitopredictsurgicaloutcomeafterneoadjuvantchemotherapyinadvancedovariancancer AT lampebjorn theimportanceoftheperitonealcancerindexpcitopredictsurgicaloutcomeafterneoadjuvantchemotherapyinadvancedovariancancer AT rawertfriederikeluise importanceoftheperitonealcancerindexpcitopredictsurgicaloutcomeafterneoadjuvantchemotherapyinadvancedovariancancer AT luengaswurzingerveronica importanceoftheperitonealcancerindexpcitopredictsurgicaloutcomeafterneoadjuvantchemotherapyinadvancedovariancancer AT claßengrafinvonspeesabrina importanceoftheperitonealcancerindexpcitopredictsurgicaloutcomeafterneoadjuvantchemotherapyinadvancedovariancancer AT baransisaher importanceoftheperitonealcancerindexpcitopredictsurgicaloutcomeafterneoadjuvantchemotherapyinadvancedovariancancer AT schuleresther importanceoftheperitonealcancerindexpcitopredictsurgicaloutcomeafterneoadjuvantchemotherapyinadvancedovariancancer AT carrizokatharina importanceoftheperitonealcancerindexpcitopredictsurgicaloutcomeafterneoadjuvantchemotherapyinadvancedovariancancer AT dizdaranca importanceoftheperitonealcancerindexpcitopredictsurgicaloutcomeafterneoadjuvantchemotherapyinadvancedovariancancer AT mallmannpeter importanceoftheperitonealcancerindexpcitopredictsurgicaloutcomeafterneoadjuvantchemotherapyinadvancedovariancancer AT lampebjorn importanceoftheperitonealcancerindexpcitopredictsurgicaloutcomeafterneoadjuvantchemotherapyinadvancedovariancancer |